中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
2期
23-24
,共2页
刁继元%谭宴林%曾育%袁小叶%李慰
刁繼元%譚宴林%曾育%袁小葉%李慰
조계원%담연림%증육%원소협%리위
肝肿瘤%热疗%化学疗法%临床分析
肝腫瘤%熱療%化學療法%臨床分析
간종류%열료%화학요법%림상분석
Liver neoplasms%Hyperthermia%Chemical therapy%Clinical analysis
目的:探讨经肝动脉加温化疗肝恶性肿瘤的价值。方法:肝恶性肿瘤50例,经肝动脉加温化疗150次。灌注温度43~45℃,流速20~50 mL/min,总量600~1000 mL,时间30~60 min。化疗药物(5-Fu 0.75~1.0 g、MMC 12~20 mg、DDP 60~80 mg)3药联用。结果:经>2次治疗,随访6~48个月,资料完整50例。近期有效率88.7%(CR 4例,PR 41例,NC 5例),术中患者均有不同程度的心窝部灼热感、全身发热及出汗等,术后不良反应与常温法相近。结论:通过导管将热疗与化疗相结合的方法治疗肝恶性肿瘤疗效肯定,且没有严重不良反应。
目的:探討經肝動脈加溫化療肝噁性腫瘤的價值。方法:肝噁性腫瘤50例,經肝動脈加溫化療150次。灌註溫度43~45℃,流速20~50 mL/min,總量600~1000 mL,時間30~60 min。化療藥物(5-Fu 0.75~1.0 g、MMC 12~20 mg、DDP 60~80 mg)3藥聯用。結果:經>2次治療,隨訪6~48箇月,資料完整50例。近期有效率88.7%(CR 4例,PR 41例,NC 5例),術中患者均有不同程度的心窩部灼熱感、全身髮熱及齣汗等,術後不良反應與常溫法相近。結論:通過導管將熱療與化療相結閤的方法治療肝噁性腫瘤療效肯定,且沒有嚴重不良反應。
목적:탐토경간동맥가온화료간악성종류적개치。방법:간악성종류50례,경간동맥가온화료150차。관주온도43~45℃,류속20~50 mL/min,총량600~1000 mL,시간30~60 min。화료약물(5-Fu 0.75~1.0 g、MMC 12~20 mg、DDP 60~80 mg)3약련용。결과:경>2차치료,수방6~48개월,자료완정50례。근기유효솔88.7%(CR 4례,PR 41례,NC 5례),술중환자균유불동정도적심와부작열감、전신발열급출한등,술후불량반응여상온법상근。결론:통과도관장열료여화료상결합적방법치료간악성종류료효긍정,차몰유엄중불량반응。
Objective:To investigate the value of hepatic artery plus hyperthermic chemotherapy on hepatic malignant tumor. Methods:50 cases of hepatic malignant tumor were treated with chemotherapy of hepatic artery heating for 150 time.Pouring temperature of 43 to 45 ℃,the velocity of 20~50 mL/min,a total of 600~1 000 mL,30~60 min time.Chemotherapy drugs(5-Fu 0.75~1.0 g,MMC 12~20 mg,DDP 60~80 mg) with 3 drugs combined.Results:After 2 or more treatment,and all of the 50 cases were followed up for 6~48 months with complete data.The short-term effective rate was 88.7%(CR 4 cases,PR 41 cases,NC 5 cases).During the operation,the patients had different degree of intraoperative heart burning,fever and sweating,the adverse reaction of postoperative as same with normal temperature technique.Conclusion:The methods of hyperthermia combined with chemotherapy through the catheter have certain curative effect in the treatment of liver malignant tumor,and no serious adverse reaction.